Table of Content

1. Table of Contents
1.1 List of Tables
1.2 List of Figures


2. Executive Summary
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Biopharmaceutical contract manufacturing Market- Key Findings, 2020


3. Strategic Imperatives on Global Biopharmaceutical contract manufacturing Market
3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Biopharmaceutical contract manufacturing Companies


4. Biopharmaceutical contract manufacturing Market Value Outlook to 2026, by Contract Type
4.1 Active Pharmaceutical Ingredient
4.2 Fill-And-Finish


5. Biopharmaceutical contract manufacturing Market Value Outlook to 2026, by Product Type
5.1 Interferons
5.2 Monoclonal Antibodies
5.3 Recombinant Hormone
5.4 Proteins
5.5 Vaccines
5.6 Vitamins
5.7 Insulin
5.8 Others


6. Biopharmaceutical contract manufacturing Market Value Outlook to 2026, by Application
6.1 Oncology
6.2 Autoimmune Diseases
6.3 Metabolic dieseases
6.4 Cardiovascular dieseases
6.5 Neurology
6.6 Infectious dieseases
6.7 others


7 Asia Pacific Biopharmaceutical contract manufacturing Market Value Outlook to 2026
7.1 Leading Biopharmaceutical contract manufacturing Types contributing to Asia Pacific market
7.2 Top Applications contributing to Asia Pacific Biopharmaceutical contract manufacturing
7.3 Top countries contributing to Asia Pacific Biopharmaceutical contract manufacturing


8 Europe Biopharmaceutical contract manufacturing Market Value Outlook to 2026
8.1 Leading Biopharmaceutical contract manufacturing Types contributing to Europe market
8.2 Top Applications contributing to Europe Biopharmaceutical contract manufacturing
8.3 Top countries contributing to Europe Biopharmaceutical contract manufacturing


9 North America Biopharmaceutical contract manufacturing Market Value Outlook to 2026
9.1 Leading Biopharmaceutical contract manufacturing Types contributing to North America market
9.2 Top Applications contributing to North America Biopharmaceutical contract manufacturing
9.3 Top countries contributing to North America Biopharmaceutical contract manufacturing


10 South and Central America Biopharmaceutical contract manufacturing Market Value Outlook to 2026
10.1 Leading Biopharmaceutical contract manufacturing Types contributing to South and Central America market
10.2 Top Applications contributing to South and Central America Biopharmaceutical contract manufacturing
10.3 Top countries contributing to South and Central America Biopharmaceutical contract manufacturing


11 Middle East Africa Biopharmaceutical contract manufacturing Market Value Outlook to 2026
11.1 Leading Biopharmaceutical contract manufacturing Types contributing to Middle East Africa market
11.2 Top Applications contributing to Middle East Africa Biopharmaceutical contract manufacturing
11.3 Top countries contributing to Middle East Africa Biopharmaceutical contract manufacturing



12 Business Profiles of Leading Companies
12.1 Business Description, SWOT and Financial Analysis of Companies in Biopharmaceutical contract manufacturing market
12.2 AGC Biologics
12.3 Boehringer Ingelheim GmbH
12.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
12.5 Inno Biologics Sdn Bhd
12.6 JRS PHARMA
12.7 Lonza
12.8 ProBioGen
12.9 Rentschler Biotechnologie GmbH
12.10 Samsung BioLogics
12.11 TOYOBO CO., LTD.


13 Recent Industry Developments


14 Appendix
14.1 OGAnalysis Expertise
14.2 Sources and Methodology
14.3 Contacts